Skip to main content
Caplight Logo









SynPhNe

SynPhNe

Private
SingaporeHealthcare & Life Scienceshttps://synphne.com

Last Round

Series A

Mar 12, 2024

Total Funding Raised

$5.52M

Company Overview

SynPhNe operates in Healthcare & Life Sciences and is based in Singapore. Its latest recorded funding round was a Series A round in March 2024.

SynPhNe is a healthtech company that provides a wearable connected health system designed to train the brain and body for neurorehabilitation.

Sector

Healthcare & Life Sciences

Verticals

Medical Devices, Telemedicine, Health IoT

Business Model

B2B

Customer Profile

Hardware Sales, Services & Consulting, Hardware + Subscription

AI Layer

Application

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Pricing history

Caplight clients see full MarketPrice™ history and secondary transactions.

Book a demo

For institutional investors. Book with your work email.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

Momentum history

Caplight clients track how buyer interest and sentiment change over time.

Book a demo

For institutional investors. Book with your work email.

SynPhNe Comparables

Compare SynPhNe with similar companies based on industry and business-model similarity.

SynPhNe comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
TRAINFES
81%
BrainQ Technologies
80%
Neurofenix
79%
Book a demo to see all comparables

For institutional investors. Book with your work email.

SynPhNe Funding Rounds

Historical fundraising activity

Data table
RoundDateAmount RaisedValuationInvestorsSources
Series AMar 12, 2024
Book a demo to see all funding rounds

For institutional investors. Book with your work email.

SynPhNe Investors

Notable investors and investment history

SynPhNe investors
InvestorRounds
NTUitiveSeries A
National Research Foundation SingaporeGrant

Market signals

Structured signals derived from secondary market and firmographic data.

  • Mar 5, 2025

    Launched next-generation wearable device for cognitive and physical function restoration.

  • Mar 12, 2024

    $5M round with NTUitive participating.

Book a demo to see all signals

For institutional investors. Book with your work email.

SynPhNe Filings

Explore SEC and related filing metadata, where available.

SynPhNe filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Book a demo

For institutional investors. Book with your work email.

Frequently Asked Questions

Common questions about SynPhNe's valuation, stock price, and market status.

Is SynPhNe a public or private company?

SynPhNe is a private company.

What is the current stock price of SynPhNe?

SynPhNe is a private company, so its shares have no public market price. Caplight tracks SynPhNe's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.

How much is SynPhNe worth (valuation)?

Valuation information for SynPhNe is not publicly available.

Can I buy SynPhNe stock?

SynPhNe shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.

When was SynPhNe's last funding round?

SynPhNe's most recent funding round was Series A on March 12, 2024.

Who are the main investors in SynPhNe?

Key investors in SynPhNe include NTUitive, National Research Foundation Singapore.

Will SynPhNe IPO soon?

No public IPO plans have been announced for SynPhNe.

How can I track SynPhNe secondary market activity?

Caplight tracks bids, offers, and trades in SynPhNe's shares on secondary markets.

Firmographic Details

HeadquartersSingapore
Employee Range11
Year Founded2013
Last FundingMar 12, 2024

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Book a demo

For institutional investors. Book with your work email.

See something wrong or outdated?